Regulation And Legal
Kabra Drugs Limited SEBI LODR Regulation 32 Exemption
Kabra Drugs Limited submits undertaking confirming non-applicability of SEBI LODR Regulation 32 for Q4 FY26.
Company certifies no share issuance via public, rights, or preferential issues during quart
